Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain

Gene Therapy volume 20, pages 1178–1183 (2013)Cite this article

Subjects

Abstract

We recently demonstrated that axonal transport of adeno-associated virus (AAV) is serotype-dependent. Thus, AAV serotype 2 (AAV2) is anterogradely transported (e.g., from cell bodies to nerve terminals) in both rat and non-human primate (NHP) brain. In contrast, AAV serotype 6 (AAV6) is retrogradely transported from terminals to neuronal cell bodies in the rat brain. However, the directionality of axonal transport of AAV6 in the NHP brain has not been determined. In this study, two Cynomolgus macaques received an infusion of AAV6 harboring green fluorescent protein (GFP) into the striatum (caudate and putamen) by magnetic resonance (MR)-guided convection-enhanced delivery. One month after infusion, immunohistochemical staining of brain sections revealed a striatal GFP expression that corresponded well with MR signal observed during gene delivery. As shown previously in rats, GFP expression was detected throughout the prefrontal, frontal and parietal cortex, as well as the substantia nigra pars compacta and thalamus, indicating retrograde transport of the vector in NHP. AAV6-GFP preferentially transduced neurons, although a few astrocytes were also transduced. Transduction of non-neuronal cells in the brain was associated with the upregulation of the major histocompatibility complex-II and lymphocytic infiltration as previously observed with AAV1 and AAV9. This contrasts with highly specific neuronal transduction in the rat brain. Retrograde axonal transport of AAV6 from a single striatal infusion permits efficient transduction of cortical neurons in significant tissue volumes that otherwise would be difficult to achieve.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Hennig AK, Levy B, Ogilvie JM, Vogler CA, Galvin N, Bassnett S et al. Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice. J Neurosci 2003; 23: 3302–3307.

    Article  CAS  PubMed Central  Google Scholar 

  2. Ciesielska A, Mittermeyer G, Hadaczek P, Kells AP, Forsayeth J, Bankiewicz KS . Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol Ther 2011; 19: 922–927.

    Article  CAS  Google Scholar 

  3. Kells AP, Hadaczek P, Yin D, Bringas J, Varenika V, Forsayeth J et al. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci USA 2009; 106: 2407–2411.

    Article  CAS  Google Scholar 

  4. Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J et al. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther 2006; 17: 291–302.

    Article  CAS  PubMed Central  Google Scholar 

  5. Salegio EA, Samaranch L, Kells AP, Mittermeyer G, San Sebastian W, Zhou S et al. Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Therapy 2013; 20: 348–352.

    Article  CAS  Google Scholar 

  6. Hadaczek P, Forsayeth J, Mirek H, Munson K, Bringas J, Pivirotto P et al. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther 2009; 20: 225–237.

    Article  CAS  PubMed Central  Google Scholar 

  7. Bobo R, Laske D, Akbasak A, Morrison P, Dedrick R, Oldfield E . Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 1994; 91: 2076–2080.

    Article  CAS  Google Scholar 

  8. Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J et al. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther 2006; 17: 291–302.

    Article  CAS  PubMed Central  Google Scholar 

  9. Fiandaca M, Forsayeth J, Dickinson P, Bankiewicz K . Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 2008; 5: 123–127.

    Article  PubMed Central  Google Scholar 

  10. Salegio EA, Samaranch L, Kells AP, Forsayeth J, Bankiewicz K . Guided delivery of adeno-associated viral vectors into the primate brain. Adv Drug Deliv Rev 2012; 64: 598–604.

    Article  CAS  PubMed Central  Google Scholar 

  11. Hadaczek P, Yamashita Y, Mirek H, Tamas L, Bohn MC, Noble C et al. The ‘perivascular pump’ driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther 2006; 14: 69–78.

    Article  CAS  PubMed Central  Google Scholar 

  12. Chamberlin NL, Du B, de Lacalle S, Saper CB . Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res 1998; 793: 169–175.

    Article  CAS  PubMed Central  Google Scholar 

  13. Salegio EA, Samaranch L, Kells AP, Mittermeyer G, San Sebastian W, Zhou S et al. Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Therapy 2012; 20: 348–352.

    Article  PubMed Central  Google Scholar 

  14. Ciesielska A, Hadaczek P, Mittermeyer G, Zhou S, Wright JF, Bankiewicz KS et al. Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol Ther 2013; 21: 158–166.

    Article  CAS  Google Scholar 

  15. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993; 72: 971–983.

    Article  Google Scholar 

  16. Walker FO . Huntington’s disease. Lancet 2007; 369: 218–228.

    Article  CAS  Google Scholar 

  17. Ross CA, Tabrizi SJ . Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10: 83–98.

    Article  CAS  Google Scholar 

  18. Vagner T, Young D, Mouravlev A . Nucleic acid-based therapy approaches for Huntington’s disease. Neurol Res Int 2012; 2012: 358370.

    Article  PubMed Central  Google Scholar 

  19. Kemp JM, Powell TP . The cortico-striate projection in the monkey. Brain 1970; 93: 525–546.

    Article  CAS  Google Scholar 

  20. Selemon LD, Goldman-Rakic PS . Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 1985; 5: 776–794.

    Article  CAS  PubMed Central  Google Scholar 

  21. Matsushita T, Elliger S, Elliiger C, Podsakoff G, Villarreal L, Kurtzman G et al. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Therapy 1998; 5: 938–945.

    Article  CAS  Google Scholar 

  22. Wright J, Qu G, Tang C, Sommer J . Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector. Curr Opin Drug Discov Dev 2003; 6: 174–178.

    CAS  Google Scholar 

  23. Krauze MT, Saito R, Noble C, Tamas M, Bringas J, Park JW et al. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 2005; 103: 923–929.

    Article  Google Scholar 

  24. Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS et al. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson’s disease. Mol Ther 2011; 19: 1048–1057.

    Article  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant to KSB from NIH-NINDS (R01NS073940-01).

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA

    W San Sebastian, L Samaranch, G Heller, A P Kells, J Bringas, P Pivirotto, J Forsayeth & K S Bankiewicz

Authors
  1. W San Sebastian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Samaranch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Heller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A P Kells
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Bringas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Pivirotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Forsayeth
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K S Bankiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K S Bankiewicz.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

San Sebastian, W., Samaranch, L., Heller, G. et al. Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Ther 20, 1178–1183 (2013). https://doi.org/10.1038/gt.2013.48

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2013.48

Keywords

This article is cited by

Search

Advanced search

Quick links